Q&A with Dr Gary Waanders Healthcare Research Director at Zeus Capital
24th January 2017
Zeus Capital’s Dr Gary Waanders discusses Motif Bio PLC in this exclusive interview with DirectorsTalk
Zeus Capital’s Dr Gary Waanders discusses Motif Bio PLC in this exclusive interview with DirectorsTalk
Allergy Therapeutics Plc (LON:AGY) is the topic of conversation when DirectorsTalk caught up with Dr Gary Waanders the Director of Healthcare Research at Zeus Capital. Gary explains whats driven growth
Motif Bio Plc (LON:MTFB) is the topic of conversation when DirectorsTalk caught up with Dr Gary Waanders the Director of Healthcare Research at Zeus Capital. Gary covers the highlights for
FY16 revenue will be £53.7m (FY15: £44.8m), in line with ZC estimate of £53.9m, showing growth of c. 20% yoy underpinned by the three acquisitions undertaken in the year. However,
With its £45m acquisition of Ronez Ltd, a vertically-integrated aggregates producer in the Channel Islands, SigmaRoc plc (LON:SRC) has emerged as a new, growth-orientated construction materials company. But utilising management’s
Safestyle UK plc (LON:SFE), the leading UK-focused retailer and manufacturer of PVCu windows and doors for the homeowner market, has today provided a trading update for the year ended 31
Following on from the positive AGM statement at the end of November, MySale Group PLC (LON:MYSL) has released an upbeat pre-close trading update. Group revenue increased 6% to A$136.1m, while
Zeus Capital’s Robin Savage discusses City of London Investment Group PLC in this exclusive interview with DirectorsTalk
City of London Investment Group Plc (LON:CLIG) is the topic of conversation with Robin Savage, research director at Zeus Capital. Robin explains why a 61% increase in its profit before
Elegant Hotels Group Plc (LON:EHG) is the topic of discussion with Mike Allen, head of research at Zeus Capital. Mike explains his take on the 2016 results, talks about key
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
